A single dose pegfilgrastim for supporting neutrophil recovery in patients treated for high-risk acute myeloid leukemia by the EMA 2000 scheduleOlfa Derbel, Xavier Thomas, Giovanna Cannas et al.|Hematology|2010Cited by 2
The rationale and use of hypomethylation agents in adult acute myeloid leukemiaXavier Thomas, Jacques Troncy, Youcef Chelghoum et al.|Expert Opinion on Drug Discovery|2009Cited by 1
A076 Long-Term Follow-up of Multiple Myeloma Patients Treated by VELCADEMarie‐Cécile Michallet, Jacques Troncy, Mohamed Sobh et al.|Clinical Lymphoma & Myeloma|2009Cited by 0
Impact of Molecular Markers and Cytogenetic Abnormalities on Long-Term Overall Survival and Disease-Free Survival after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Acute Myeloid Leukemia (AML) patientsMauricette Michallet, Sandrine Hayette, Mohamad Sobh et al.|Blood|2008Cited by 0
Long-Term Follow-up of Multiple Myeloma Patients Treated by Bortezomib (Velcade®): A Study on Efficacy, Tolerance, Survival and Time to ProgressionMauricette Michallet, Jacques Troncy, Mohamad Sobh et al.|Blood|2008Cited by 0